{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:01:13Z","timestamp":1794898873651,"version":"4.9.1"},"reference-count":150,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The placental barrier is a critical interface that regulates drug transport between maternal and fetal circulation and is an important component in assessing fetal drug-exposure risk. Since pregnant women are often excluded from clinical trials, pharmacokinetic (PK) analysis data on placental drug transport remain limited. Currently,\n                      <jats:italic>in vitro<\/jats:italic>\n                      experiments and\n                      <jats:italic>in silico<\/jats:italic>\n                      simulation strategies are the primary and effective means for understanding drug transport across the placenta.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>\n                      Various\n                      <jats:italic>in vitro<\/jats:italic>\n                      experimental methods, including cell monolayer models,\n                      <jats:italic>ex vivo<\/jats:italic>\n                      placental perfusion, and organ-on-a-chip platforms, along with model-based computational simulations, were systematically reviewed. The advantages, limitations, and potential future applications of these methods were evaluated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>\n                      A total of seven studies using cell models, 28 employing\n                      <jats:italic>ex vivo<\/jats:italic>\n                      perfusion, six utilizing placenta-on-a-chip technology, and 39 focusing on\n                      <jats:italic>in silico<\/jats:italic>\n                      simulations, were identified, involving 8, 34, 5, and 42 drugs, respectively. Antiviral agents, antibiotics, and opioids were the most frequently investigated drug types. Overall,\n                      <jats:italic>in silico<\/jats:italic>\n                      simulations informed by\n                      <jats:italic>in vitro<\/jats:italic>\n                      data as baseline parameters and constraints demonstrated higher predictive accuracy. Integrating multi-model data was shown to be a reliable strategy for improving the precision of placental PK studies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This review highlights the current strategies in placental PK research and supports safer drug use during pregnancy. Multi-model data integration is essential for developing reliable and quantitative fetal drug-exposure assessment frameworks, thus addressing data gaps caused by the exclusion of pregnant women from clinical trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2025.1694886","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:21:05Z","timestamp":1761546065000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Strategy advancements in placental pharmacokinetics: from in vitro experiments to in silico prediction"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhimin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1124\/dmd.121.000711","article-title":"Prediction of maternal and fetoplacental concentrations of cefazolin, cefuroxime, and amoxicillin during pregnancy using Bottom-Up physiologically based pharmacokinetic models","volume":"50","author":"Abduljalil","year":"","journal-title":"Drug Metab. Dispos."},{"key":"B2","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s40262-021-01103-0","article-title":"Prediction of maternal and fetal Acyclovir, emtricitabine, lamivudine, and metformin concentrations during pregnancy using a physiologically based pharmacokinetic modeling approach","volume":"61","author":"Abduljalil","year":"","journal-title":"Clin. Pharmacokinet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"840710","DOI":"10.3389\/fped.2022.840710","article-title":"Application of a physiologically based pharmacokinetic approach to predict theophylline pharmacokinetics using virtual Non-Pregnant, pregnant, fetal, Breast-Feeding, and neonatal populations","volume":"10","author":"Abduljalil","year":"","journal-title":"Front. Pediatr."},{"key":"B4","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3390\/pharmaceutics16040474","article-title":"An application of a physiologically based pharmacokinetic approach to predict ceftazidime pharmacokinetics in a pregnant population","volume":"16","author":"Abduljalil","year":"2024","journal-title":"Pharmaceutics"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e002919","DOI":"10.1136\/bmjdrc-2022-002919","article-title":"Major malformations risk following early pregnancy exposure to metformin: a systematic review and meta-analysis","volume":"11","author":"Abolhassani","year":"2023","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"B6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.placenta.2020.12.014","article-title":"Research on nanoparticles in human perfused placenta: state of the art and perspectives","volume":"104","author":"Aengenheister","year":"2021","journal-title":"Placenta"},{"key":"B7","doi-asserted-by":"publisher","first-page":"100007","DOI":"10.1124\/dmd.124.001824","article-title":"Absolute membrane protein abundance of P-glycoprotein, breast cancer resistance protein, and multidrug resistance proteins in term human placenta tissue and commonly used cell systems: application in physiologically based pharmacokinetic modeling of placental drug disposition","volume":"53","author":"Al-Majdoub","year":"2025","journal-title":"Drug Metab. Dispos."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1002\/psp4.12674","article-title":"Estimating fetal exposure to the P-gp substrates, corticosteroids, by PBPK modeling to inform prevention of neonatal respiratory distress syndrome","volume":"10","author":"Anoshchenko","year":"2021","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/s41574-020-0372-6","article-title":"Tracking placental development in health and disease","volume":"16","author":"Aplin","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s0169-409x(00)00128-9","article-title":"Caco-2 monolayers in experimental and theoretical predictions of drug transport","volume":"46","author":"Artursson","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"105068","DOI":"10.1016\/j.ejps.2019.105068","article-title":"Using mechanistic physiologically-based pharmacokinetic models to assess prenatal drug exposure: thalidomide versus efavirenz as case studies","volume":"140","author":"Atoyebi","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/bcp.16006","article-title":"Physiologically-based pharmacokinetic modelling of long-acting injectable cabotegravir and rilpivirine in pregnancy","volume":"91","author":"Atoyebi","year":"2024","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0172174","DOI":"10.1371\/journal.pone.0172174","article-title":"The effects of pravastatin on the normal human placenta: lessons from ex-vivo models","volume":"12","author":"Balan","year":"2017","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"108521","DOI":"10.1016\/j.jsat.2021.108521","article-title":"Precision dosing of methadone during pregnancy: a pharmacokinetics virtual clinical trials study","volume":"130","author":"Badhan","year":"2021","journal-title":"J. Subst. Abuse Treat."},{"key":"B15","doi-asserted-by":"publisher","first-page":"879","DOI":"10.16438\/j.0513-4870.2015-0861","article-title":"Expression and regulation of drug transporters in placenta","volume":"51","author":"Bai","year":"2016","journal-title":"Yao Xue Xue Bao"},{"key":"B16","doi-asserted-by":"publisher","first-page":"710.e1","DOI":"10.1016\/j.ajog.2015.06.065","article-title":"Rivaroxaban transfer across the dually perfused isolated human placental cotyledon","volume":"213","author":"Bapat","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s40264-024-01482-w","article-title":"The use of multiple medications during pregnancy among an ethnically diverse population in South-Eastern Melbourne: a retrospective analysis to explore potential risks and complications","volume":"48","author":"Belsti","year":"2025","journal-title":"Drug Saf."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1111\/epi.17395","article-title":"Lacosamide effects on placental carriers of essential compounds in comparison with valproate: studies in perfused human placentas","volume":"63","author":"Berman","year":"2022","journal-title":"Epilepsia"},{"key":"B19","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/nbt.2989","article-title":"Microfluidic organs-on-chips","volume":"32","author":"Bhatia","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejps.2018.02.032","article-title":"Evaluation of drug permeation under fed state conditions using mucus-covered Caco-2 cell epithelium","volume":"118","author":"Birch","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1700786","DOI":"10.1002\/adhm.201700786","article-title":"Placental Drug Transport-on-a-Chip: a microengineered in vitro model of transporter-mediated Drug efflux in the human placental barrier","volume":"7","author":"Blundell","year":"2018","journal-title":"Adv. Healthc. Mater"},{"key":"B22","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1111\/bph.15931","article-title":"Pentoxifylline as a therapeutic option for pre-eclampsia: a study on its placental effects","volume":"179","author":"Broekhuizen","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/s40262-022-01127-0","article-title":"Prediction of maternal and fetal doravirine exposure by integrating physiologically based pharmacokinetic modeling and human placenta perfusion experiments","volume":"61","author":"Bukkems","year":"2022","journal-title":"Clin. Pharmacokinet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.17925\/EE.2024.20.1.5","article-title":"The placental role in gestational diabetes mellitus: a molecular perspective","volume":"20","author":"Calvo","year":"2024","journal-title":"touchREV Endocrinol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e13469","DOI":"10.1111\/cpr.13469","article-title":"Self-assembled human placental model from trophoblast stem cells in a dynamic organ-on-a-chip system","volume":"56","author":"Cao","year":"2023","journal-title":"Cell. Prolif."},{"key":"B26","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1080\/14740338.2019.1634689","article-title":"Human organotypic bioconstructs from organ-on-chip devices for human-predictive biological insights on drug candidates","volume":"18","author":"Cavero","year":"2019","journal-title":"Expert Opin. Drug Saf."},{"key":"B27","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1440-1681.2006.04324.x","article-title":"Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo","volume":"33","author":"Ceckova","year":"2006","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1124\/dmd.118.083329","article-title":"Equilibrative nucleoside transporter 1 (ENT1, SLC29A1) facilitates transfer of the antiretroviral drug abacavir across the placenta","volume":"46","author":"Cerveny","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"B29","doi-asserted-by":"publisher","first-page":"106349","DOI":"10.1016\/j.ejps.2022.106349","article-title":"Application of PBPK modeling in predicting maternal and fetal pharmacokinetics of levetiracetam during pregnancy","volume":"181","author":"Chen","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"106707","DOI":"10.1016\/j.ejps.2024.106707","article-title":"Physiologically based pharmacokinetic modeling to predict maternal pharmacokinetics and fetal carbamazepine exposure during pregnancy","volume":"194","author":"Chen","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jconrel.2023.07.040","article-title":"An artificial intelligence-assisted physiologically-based pharmacokinetic model to predict nanoparticle delivery to tumors in mice","volume":"361","author":"Chou","year":"2023","journal-title":"J. Control Release"},{"key":"B32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.placenta.2010.12.024","article-title":"Studying placental transfer of highly purified non-dioxin-like PCBs in two models of the placental barrier","volume":"32","author":"Correia Carreira","year":"2011","journal-title":"Placenta"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s40262-017-0539-z","article-title":"Gestation-Specific changes in the anatomy and physiology of healthy pregnant women: an extended repository of model parameters for physiologically based pharmacokinetic modeling in pregnancy","volume":"56","author":"Dallmann","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1002\/cpt.1084","article-title":"Physiologically based pharmacokinetic modeling in pregnancy: a systematic review of published models","volume":"104","author":"Dallmann","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.jaci.2021.07.005","article-title":"Safety of anti-TNF agents in pregnancy","volume":"148","author":"De Felice","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/bcp.12815","article-title":"Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models","volume":"81","author":"De Sousa Mendes","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s40262-016-0457-5","article-title":"A physiologically-based pharmacokinetic model to predict human fetal exposure for a drug metabolized by several CYP450 pathways","volume":"56","author":"De Sousa Mendes","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"B36","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s10616-017-0142-z","article-title":"Co-culture of JEG-3, BeWo and syncBeWo cell lines with adrenal H295R cell line: an alternative model for examining endocrine and metabolic properties of the fetoplacental unit","volume":"70","author":"Drwal","year":"2018","journal-title":"Cytotechnology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/cpt.1827","article-title":"Assessment of placental disposition of Infliximab and etanercept in women with autoimmune diseases and in the Ex Vivo perfused placenta","volume":"108","author":"Eliesen","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.3390\/jcm12134315","article-title":"Placenta-on-a-Chip as an in vitro approach to evaluate the physiological and structural characteristics of the human placental barrier upon drug exposure: a systematic review","volume":"12","author":"Elzinga","year":"2023","journal-title":"J. Clin. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nrd4539","article-title":"Organs-on-chips at the frontiers of drug discovery","volume":"14","author":"Esch","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e0232140","DOI":"10.1371\/journal.pone.0232140","article-title":"Placental transfer of Letermovir and Maribavir in the ex vivo human cotyledon perfusion model. New perspectives for in utero treatment of congenital cytomegalovirus infection","volume":"15","author":"Faure Bardon","year":"2020","journal-title":"PLoS One"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.3390\/ph15121533","article-title":"HIV-1 integrase strand transfer inhibitors and neurodevelopment","volume":"15","author":"Foster","year":"2022","journal-title":"Pharm. (Basel)."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1002\/cpt.1748","article-title":"Assessment of maternal and fetal Dolutegravir exposure by integrating Ex Vivo placental perfusion data and physiologically-based pharmacokinetic modeling","volume":"107","author":"Freriksen","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e70151","DOI":"10.1111\/jcmm.70151","article-title":"Modelling the maternal-fetal interface: an in vitro approach to investigate nutrient and drug transport across the human placenta","volume":"28","author":"Fuenzalida","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"771818","DOI":"10.3389\/fphar.2021.771818","article-title":"Organic anion transporting polypeptide 2B1 in human fetal membranes: a novel gatekeeper for drug transport during pregnancy?","volume":"12","author":"Ganguly","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/nprot.2012.144","article-title":"Ex vivo perfusion of mid-to-late-gestation mouse placenta for maternal-fetal interaction studies during pregnancy","volume":"8","author":"Goeden","year":"2013","journal-title":"Nat. Protoc."},{"key":"B47","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.toxlet.2024.02.012","article-title":"A chirality-sensitive approach to predict chemical transfer across the human placental barrier","volume":"394","author":"Gomatam","year":"2024","journal-title":"Toxicol. Lett."},{"key":"B48","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/AOG.0000000000002579","article-title":"Prescription and other medication use in pregnancy","volume":"131","author":"Haas","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1080\/17425255.2018.1499726","article-title":"An update on expression and function of P-gp\/ABCB1 and BCRP\/ABCG2 in the placenta and fetus","volume":"14","author":"Han","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1042\/CS20150702","article-title":"The role of inflammation in the pathology of preeclampsia","volume":"130","author":"Harmon","year":"2016","journal-title":"Clin. Sci. (Lond)."},{"key":"B51","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.placenta.2024.08.014","article-title":"Long-term culture and passaging of term trophoblast for the investigation of syncytiotrophoblast function","volume":"166","author":"Hawkins","year":"2025","journal-title":"Placenta"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.3390\/pharmaceutics14112367","article-title":"Application of physiologically based pharmacokinetic modeling to predict maternal pharmacokinetics and fetal exposure to oxcarbazepine","volume":"14","author":"He","year":"2022","journal-title":"Pharmaceutics"},{"key":"B53","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.placenta.2021.12.007","article-title":"Transplacental transfer of venlafaxine evaluated by ex vivo perfusion","volume":"117","author":"Hirschmugl","year":"2022","journal-title":"Placenta"},{"key":"B54","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.ebiom.2019.06.007","article-title":"Placental effects and transfer of sildenafil in healthy and preeclamptic conditions","volume":"45","author":"Hitzerd","year":"2019","journal-title":"EBioMedicine"},{"key":"B56","doi-asserted-by":"publisher","first-page":"E3882","DOI":"10.1073\/pnas.1604747113","article-title":"Human pluripotent stem cells as a model of trophoblast differentiation in both normal development and disease","volume":"113","author":"Horii","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1080\/14767058.2016.1211634","article-title":"Transplacental transfer of oseltamivir phosphate and its metabolite oseltamivir carboxylate using the ex vivo human placenta perfusion model in Chinese Hans population","volume":"30","author":"Huang","year":"2017","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1093\/annonc\/mdv172","article-title":"Variation in transplacental transfer of tyrosine kinase inhibitors in the human perfused cotyledon model","volume":"26","author":"Jovelet","year":"2015","journal-title":"Ann. Oncol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"120867","DOI":"10.1016\/j.lfs.2022.120867","article-title":"Expression of CYP450 enzymes in human fetal membranes and its implications in xenobiotic metabolism during pregnancy","volume":"307","author":"Kammala","year":"2022","journal-title":"Life Sci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1241815","DOI":"10.3389\/fphar.2023.1241815","article-title":"Microfluidic technology and simulation models in studying pharmacokinetics during pregnancy","volume":"14","author":"Kammala","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.3390\/ijms22041704","article-title":"Revisiting steroidogenic pathways in the human placenta and primary human trophoblast cells","volume":"22","author":"Karahoda","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"108505","DOI":"10.1016\/j.jbc.2025.108505","article-title":"Derivation of human trophoblast stem cells from placentas at birth","volume":"301","author":"Karakis","year":"2025","journal-title":"J. Biol. Chem."},{"key":"B64","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.placenta.2017.10.011","article-title":"Role of nucleoside transporters in transplacental pharmacokinetics of nucleoside reverse transcriptase inhibitors zidovudine and emtricitabine","volume":"60","author":"Karbanova","year":"2017","journal-title":"Placenta"},{"key":"B65","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/17512433.2018.1425615","article-title":"The role of the placenta in drug transport and fetal drug exposure","volume":"11","author":"Koren","year":"2018","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1111\/all.15468","article-title":"The impact of maternal-fetal omalizumab transfer on peanut-specific responses in an ex vivo placental perfusion model","volume":"77","author":"Kothari","year":"2022","journal-title":"Allergy"},{"key":"B67","doi-asserted-by":"publisher","first-page":"116177","DOI":"10.1016\/j.biopha.2024.116177","article-title":"Safety assessment of the SGLT2 inhibitors empagliflozin, dapagliflozin and canagliflozin during pregnancy: an ex vivo human placenta perfusion and in vitro study","volume":"171","author":"Kuoni","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"B68","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.placenta.2024.11.007","article-title":"A transcriptomic comparison of in vitro models of the human placenta","volume":"159","author":"Lapehn","year":"2024","journal-title":"Placenta"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1111\/bcp.15826","article-title":"Quantification of sertraline maternal\/fetal ratio and amniotic fluid concentration using a pregnancy physiologically based pharmacokinetic model","volume":"91","author":"Lartey","year":"2023","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/pharmaceutics16010096","article-title":"PBPK modeling approach to predict the behavior of drugs cleared by metabolism in pregnant subjects and fetuses","volume":"16","author":"Le Merdy","year":"2024","journal-title":"Pharmaceutics"},{"key":"B70","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12958-015-0070-8","article-title":"Isolation, purification and in vitro differentiation of cytotrophoblast cells from human term placenta","volume":"13","author":"Li","year":"2015","journal-title":"Reprod. Biol. Endocrinol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1111\/bcp.15589","article-title":"Foetal and neonatal exposure prediction and dosing evaluation for ampicillin using a physiologically-based pharmacokinetic modelling approach","volume":"89","author":"Li","year":"2023","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s00204-013-1074-9","article-title":"Assessment of an in vitro transport model using BeWo b30 cells to predict placental transfer of compounds","volume":"87","author":"Li","year":"2013","journal-title":"Arch. Toxicol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1007\/s11095-024-03725-y","article-title":"A combination of machine learning and PBPK modeling approach for pharmacokinetics prediction of small molecules in humans","volume":"41","author":"Li","year":"2024","journal-title":"Pharm. Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1007\/s40262-020-00897-9","article-title":"Prediction of maternal and fetal pharmacokinetics of Dolutegravir and Raltegravir using physiologically based pharmacokinetic modeling","volume":"59","author":"Liu","year":"","journal-title":"Clin. Pharmacokinet."},{"key":"B75","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/jcph.1515","article-title":"Physiologically based pharmacokinetic models to predict maternal pharmacokinetics and fetal exposure to emtricitabine and acyclovir","volume":"60","author":"Liu","year":"","journal-title":"J. Clin. Pharmacol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s40262-020-00977-w","article-title":"Physiologically based pharmacokinetic modeling framework to predict neonatal pharmacokinetics of transplacentally acquired emtricitabine, Dolutegravir, and Raltegravir","volume":"60","author":"Liu","year":"2021","journal-title":"Clin. Pharmacokinet."},{"key":"B77","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s40262-023-01323-6","article-title":"Development of a generic fetal physiologically based pharmacokinetic model and prediction of human maternal and fetal organ concentrations of cefuroxime","volume":"63","author":"Liu","year":"2024","journal-title":"Clin. Pharmacokinet."},{"key":"B78","doi-asserted-by":"publisher","first-page":"e1144","DOI":"10.1002\/hsr2.1144","article-title":"Transplacental transfer of Remdesivir and GS-441524: an ex vivo perfusion study","volume":"6","author":"Louchet","year":"2023","journal-title":"Health Sci. Rep."},{"key":"B79","doi-asserted-by":"publisher","first-page":"e004365","DOI":"10.1136\/bmjopen-2013-004365","article-title":"Medication use in pregnancy: a cross-sectional, multinational web-based study","volume":"4","author":"Lupattelli","year":"2014","journal-title":"BMJ Open"},{"key":"B80","doi-asserted-by":"publisher","first-page":"1068153","DOI":"10.3389\/fphar.2023.1068153","article-title":"PBPK-based dose finding for sildenafil in pregnant women for antenatal treatment of congenital diaphragmatic hernia","volume":"14","author":"Macente","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2350\/12-08-1243-OA.1","article-title":"Pathologic evaluation of normal and perfused term placental tissue","volume":"17","author":"Maroun","year":"2014","journal-title":"Pediatr. Dev. Pathol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.reprotox.2010.01.006","article-title":"Quality assessment of a placental perfusion protocol","volume":"30","author":"Mathiesen","year":"2010","journal-title":"Reprod. Toxicol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"e70073","DOI":"10.1111\/bcpt.70073","article-title":"Models of endocrine-disrupting effects: human placental steroidogenesis","volume":"137","author":"Mathiesen","year":"2025","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41579-021-00610-y","article-title":"Infections at the maternal-fetal interface: an overview of pathogenesis and defence","volume":"20","author":"Megli","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s40262-020-00861-7","article-title":"Integration of placental transfer in a fetal\u2013maternal physiologically based pharmacokinetic model to characterize acetaminophen exposure and metabolic clearance in the fetus","volume":"59","author":"Mian","year":"2020","journal-title":"Clin. Pharmacokinet."},{"key":"B87","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.placenta.2022.03.129","article-title":"Effects of aldosterone on the human placenta: insights from placental perfusion studies","volume":"123","author":"Mistry","year":"2022","journal-title":"Placenta"},{"key":"B88","doi-asserted-by":"publisher","first-page":"C694","DOI":"10.1152\/ajpcell.00177.2021","article-title":"Syncytialization alters the extracellular matrix and barrier function of placental trophoblasts","volume":"321","author":"Moore","year":"2021","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1177\/1535370219851109","article-title":"Placental trophoblast transfer of opioids following exposures to individual or mixtures of opioids in vitro","volume":"244","author":"Mortensen","year":"2019","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"B90","doi-asserted-by":"publisher","first-page":"8755","DOI":"10.3390\/ijms21228755","article-title":"Development of an Organ-on-a-Chip-Device for study of placental pathologies","volume":"21","author":"Mosavati","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.placenta.2024.07.307","article-title":"Isolation of pure primary term human cytotrophoblasts and their differentiation into syncytiotrophoblast-like cells as an ex vivo model of the human placenta","volume":"166","author":"Motomura","year":"2025","journal-title":"Placenta"},{"key":"B92","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.placenta.2021.07.289","article-title":"Intrapartum transfer of oxytocin across the human placenta: an ex vivo perfusion experiment","volume":"112","author":"Nathan","year":"2021","journal-title":"Placenta"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1002\/psp4.13251","article-title":"Using PBPK modeling to supplement clinical data and support the safe and effective use of dolutegravir in pregnant and lactating women","volume":"13","author":"Ning","year":"2024","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"670.e1","DOI":"10.1016\/j.ajog.2021.05.032","article-title":"Therapeutic concentration of ciprofloxacin and transfer across the human term placenta","volume":"225","author":"Noergaard","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12896-020-00637-8","article-title":"Development of Caco-2 cells expressing four CYPs via a Mammalian artificial chromosome","volume":"20","author":"Ohta","year":"2020","journal-title":"BMC Biotechnol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.stem.2017.11.004","article-title":"Derivation of human trophoblast stem cells","volume":"22","author":"Okae","year":"2018","journal-title":"Cell. Stem Cell."},{"key":"B97","doi-asserted-by":"publisher","first-page":"5759","DOI":"10.3390\/ijms22115759","article-title":"Interaction between metformin, folate and vitamin B(12) and the potential impact on fetal growth and long-term metabolic health in diabetic pregnancies","volume":"22","author":"Owen","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B98","doi-asserted-by":"publisher","first-page":"108519","DOI":"10.1016\/j.reprotox.2023.108519","article-title":"Establishment of a 3D multicellular placental microtissues for investigating the effect of antidepressant vortioxetine","volume":"123","author":"\u00d6zt\u00fcrk","year":"2024","journal-title":"Reprod. Toxicol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1079\/pns19910044","article-title":"Perfusion of isolated human placenta","volume":"50","author":"Page","year":"1991","journal-title":"Proc. Nutr. Soc."},{"key":"B100","doi-asserted-by":"publisher","first-page":"122004","DOI":"10.1016\/j.ijpharm.2022.122004","article-title":"The Caco-2 model: modifications and enhancements to improve efficiency and predictive performance","volume":"624","author":"Panse","year":"2022","journal-title":"Int. J. Pharm."},{"key":"B101","doi-asserted-by":"publisher","first-page":"e1002160","DOI":"10.1371\/journal.pmed.1002160","article-title":"Pregnancy-Associated changes in pharmacokinetics: a systematic review","volume":"13","author":"Pariente","year":"2016","journal-title":"PLoS Med."},{"key":"B102","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1053\/j.semperi.2014.10.003","article-title":"Placental hypoxia: the lesions of maternal malperfusion","volume":"39","author":"Parks","year":"2015","journal-title":"Semin. Perinatol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1124\/dmd.120.000322","article-title":"Development and verification of a linked \u0394 (9)-THC\/11-OH-THC physiologically based pharmacokinetic model in healthy, nonpregnant population and extrapolation to pregnant women","volume":"49","author":"Patilea-Vrana","year":"2021","journal-title":"Drug Metab. Dispos."},{"key":"B104","doi-asserted-by":"publisher","first-page":"20190031","DOI":"10.1098\/rsfs.2019.0031","article-title":"Drug transport across the human placenta: review of placenta-on-a-chip and previous approaches","volume":"9","author":"Pemathilaka","year":"","journal-title":"Interface Focus"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1800112","DOI":"10.1002\/gch2.201800112","article-title":"Placenta-on-a-Chip: in vitro Study of caffeine transport across placental barrier using liquid chromatography Mass spectrometry","volume":"3","author":"Pemathilaka","year":"","journal-title":"Glob. Chall."},{"key":"B106","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1021\/acsabm.2c00121","article-title":"Transport of maternally administered pharmaceutical agents across the placental barrier in vitro","volume":"5","author":"Pemathilaka","year":"2022","journal-title":"ACS Appl. Bio Mater"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1097\/QAD.0000000000002637","article-title":"Placental transfer of the integrase strand inhibitors cabotegravir and bictegravir in the ex-vivo human cotyledon perfusion model","volume":"34","author":"Pencol\u00e9","year":"2020","journal-title":"Aids"},{"key":"B108","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1136\/jnnp-2024-333530","article-title":"Trends in the prevalence and pharmacological management of migraine during pregnancy in the UK, 2000-2018","volume":"95","author":"Phillips","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B109","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/bcp.14960","article-title":"Prediction of maternal and fetal pharmacokinetics of indomethacin in pregnancy","volume":"88","author":"Pillai","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s11095-021-03035-7","article-title":"Chiral transplacental pharmacokinetics of fexofenadine: impact of P-Glycoprotein inhibitor fluoxetine using the human placental perfusion model","volume":"38","author":"Pinto","year":"2021","journal-title":"Pharm. Res."},{"key":"B111","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.2147\/DDDT.S181493","article-title":"The role of various transporters in the placental uptake of ofloxacin in an in vitro model of human villous trophoblasts","volume":"12","author":"Polachek","year":"2018","journal-title":"Drug Des. Devel Ther."},{"key":"B112","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jri.2016.04.284","article-title":"Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): consequences for FcRn-mediated in vitro transcytosis and ex vivo human placental transfer","volume":"116","author":"Porter","year":"2016","journal-title":"J. Reprod. Immunol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.tiv.2009.07.028","article-title":"Modeling placental transport: correlation of in vitro BeWo cell permeability and ex vivo human placental perfusion","volume":"23","author":"Poulsen","year":"2009","journal-title":"Toxicol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"4574","DOI":"10.1039\/d2lc00691j","article-title":"Testing of drugs using human feto-maternal interface organ-on-chips provide insights into pharmacokinetics and efficacy","volume":"22","author":"Richardson","year":"2022","journal-title":"Lab. Chip"},{"key":"B115","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.preghy.2012.01.001","article-title":"The placenta in preeclampsia","volume":"2","author":"Roberts","year":"2012","journal-title":"Pregnancy Hypertens."},{"key":"B116","doi-asserted-by":"publisher","first-page":"105471","DOI":"10.1016\/j.tiv.2022.105471","article-title":"Predicting fetal exposure of crizotinib during pregnancy: combining human ex vivo placenta perfusion data with physiologically-based pharmacokinetic modeling","volume":"85","author":"Roelofsen","year":"2022","journal-title":"Toxicol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10565-005-0085-6","article-title":"The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics","volume":"21","author":"Sambuy","year":"2005","journal-title":"Cell. Biol. Toxicol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/jac\/dkv358","article-title":"Placental transfer of the HIV integrase inhibitor dolutegravir in an ex Vivo human cotyledon perfusion model","volume":"71","author":"Schalkwijk","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"B119","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s40262-017-0583-8","article-title":"Prediction of fetal Darunavir exposure by integrating human Ex-Vivo placental transfer and physiologically based pharmacokinetic modeling","volume":"57","author":"Schalkwijk","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"B120","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/j.placenta.2008.11.004","article-title":"Tolerance of human placental tissue to severe hypoxia and its relevance for dual ex vivo perfusion","volume":"30","author":"Schneider","year":"2009","journal-title":"Placenta"},{"key":"B121","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/j.placenta.2014.11.022","article-title":"IFPA senior award lecture: energy metabolism of human placental tissue studied by ex vivo perfusion of an isolated cotyledon","volume":"36","author":"Schneider","year":"2015","journal-title":"Placenta"},{"key":"B122","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.placenta.2021.02.017","article-title":"Ex vivo dual perfusion of an isolated cotyledon of human placenta: history and future challenges","volume":"107","author":"Schneider","year":"2021","journal-title":"Placenta"},{"key":"B123","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.placenta.2022.05.003","article-title":"Ex vivo dual perfusion of an isolated human placenta cotyledon: towards protocol standardization and improved inter-centre comparability","volume":"126","author":"Schneider","year":"2022","journal-title":"Placenta"},{"key":"B124","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.devcel.2024.01.023","article-title":"Single-cell assessment of primary and stem cell-derived human trophoblast organoids as placenta-modeling platforms","volume":"59","author":"Shannon","year":"2024","journal-title":"Dev. Cell."},{"key":"B125","doi-asserted-by":"publisher","first-page":"734122","DOI":"10.3389\/fped.2021.734122","article-title":"Mechanistic modeling of maternal lymphoid and fetal plasma antiretroviral exposure during the third trimester","volume":"9","author":"Shenkoya","year":"2021","journal-title":"Front. Pediatr."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1002\/psp4.13252","article-title":"Physiologically based pharmacokinetic modeling of long-acting extended-release naltrexone in pregnant women with opioid use disorder","volume":"13","author":"Shenkoya","year":"2024","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"166131","DOI":"10.1016\/j.bbadis.2021.166131","article-title":"Dynamic placenta-on-a-chip model for fetal risk assessment of nanoparticles intended to treat pregnancy-associated diseases","volume":"1867","author":"Shojaei","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B128","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1039\/c7lc90068f","article-title":"Organ-body- and disease-on-a-chip systems","volume":"17","author":"Shuler","year":"2017","journal-title":"Lab. Chip"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1124\/dmd.121.000612","article-title":"Predicting maternal-fetal disposition of fentanyl following intravenous and epidural administration using physiologically based pharmacokinetic modeling","volume":"49","author":"Shum","year":"2021","journal-title":"Drug Metab. Dispos."},{"key":"B132","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12916-022-02722-5","article-title":"Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019","volume":"21","author":"Subramanian","year":"2023","journal-title":"BMC Med."},{"key":"B133","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1208\/s12248-021-00603-y","article-title":"PBPK modeling approach to predict the behavior of drugs cleared by kidney in pregnant subjects and fetus","volume":"23","author":"Szeto","year":"2021","journal-title":"Aaps J."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1111\/aogs.14805","article-title":"Use of medication in pregnancy on the rise: study on 1.4 million Danish pregnancies from 1998 to 2018","volume":"103","author":"Thunbo","year":"2024","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"B35","doi-asserted-by":"publisher","first-page":"228.e1","DOI":"10.1016\/j.ajog.2024.05.012","article-title":"Optimization of the betamethasone and dexamethasone dosing regimen during pregnancy: a combined placenta perfusion and pregnancy physiologically based pharmacokinetic modeling approach","volume":"232","author":"Van Der Heijden","year":"2024","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3390\/pharmaceutics16030375","article-title":"Forecasting fetal buprenorphine exposure through maternal-fetal physiologically based pharmacokinetic modeling","volume":"16","author":"van Hoogdalem","year":"2024","journal-title":"Pharmaceutics"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1007\/s13346-024-01715-6","article-title":"Targeted lipid nanoparticles to prevent trans-placental passage in the ex vivo human placental cotyledon perfusion model","volume":"15","author":"van Kammen","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2025.05.001","article-title":"Current approaches and advances in placental toxicology","author":"Veiga-Lopez","year":"2025","journal-title":"Trends Endocrinol. Metab"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1039\/d3lc00998j","article-title":"Endocrine-disrupting compounds and their impact on human placental function: evidence from placenta organ-on-chip studies","volume":"24","author":"Vidal","year":"2024","journal-title":"Lab. Chip"},{"key":"B137","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1161\/HYPERTENSIONAHA.123.21205","article-title":"Placenta-Derived extracellular vesicles from preeclamptic pregnancies impair vascular endothelial function via lectin-like oxidized LDL Receptor-1","volume":"80","author":"Villalobos-Labra","year":"2023","journal-title":"Hypertension"},{"key":"B138","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00125-020-05290-6","article-title":"Compromised barrier integrity of human feto-placental vessels from gestational diabetic pregnancies is related to downregulation of occludin expression","volume":"64","author":"Villota","year":"2021","journal-title":"Diabetologia"},{"key":"B139","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1080\/17460441.2020.1735347","article-title":"Advances in cell-based permeability assays to screen drugs for intestinal absorption","volume":"15","author":"Volpe","year":"2020","journal-title":"Expert Opin. Drug Discov."},{"key":"B140","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s11095-024-03675-5","article-title":"Monte Carlo optimization method based QSAR modeling of placental barrier permeability","volume":"41","author":"Vukomanovi\u0107","year":"2024","journal-title":"Pharm. Res."},{"key":"B141","doi-asserted-by":"publisher","first-page":"648388","DOI":"10.3389\/fphar.2021.648388","article-title":"Organic cation transporter 1 an intestinal uptake transporter: fact or fiction?","volume":"12","author":"Wenzel","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/jcph.2404","article-title":"Mechanistic framework to predict maternal-placental-fetal pharmacokinetics of nifedipine employing physiologically based pharmacokinetic modeling approach","volume":"64","author":"Werdan Rom\u00e3o","year":"2024","journal-title":"J. Clin. Pharmacol."},{"key":"B143","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1038\/s41590-024-01971-1","article-title":"Regulators of placental antibody transfer through a modeling lens","volume":"25","author":"Wessel","year":"2024","journal-title":"Nat. Immunol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"S963","DOI":"10.1016\/j.ajog.2020.10.023","article-title":"An integrated model of preeclampsia: a multifaceted syndrome of the maternal cardiovascular-placental-fetal array","volume":"226","author":"Yagel","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s11095-024-03705-2","article-title":"Evaluation of various approaches to estimate transplacental clearance of Vancomycin for predicting fetal concentrations using a maternal-fetal physiologically based pharmacokinetic model","volume":"41","author":"Yan","year":"2024","journal-title":"Pharm. Res."},{"key":"B146","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.placenta.2024.03.006","article-title":"Beyond 2D: novel biomaterial approaches for modeling the placenta","volume":"157","author":"Zambuto","year":"2024","journal-title":"Placenta"},{"key":"B147","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1124\/dmd.116.073957","article-title":"Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model II: verification of the model for passive placental permeability drugs","volume":"45","author":"Zhang","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"B148","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1124\/dmd.117.075192","article-title":"Development of a novel maternal-fetal physiologically based pharmacokinetic model I: insights into factors that determine fetal drug exposure through simulations and sensitivity analyses","volume":"45","author":"Zhang","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"B149","doi-asserted-by":"publisher","first-page":"21166","DOI":"10.1021\/acs.est.4c09416","article-title":"Trans-Placental transfer mechanisms of aromatic amine antioxidants (AAs) and p-Phenylenediamine quinones (PPD-Qs): evidence from human gestation exposure and the Rat Uterine perfusion model","volume":"58","author":"Zhang","year":"2024","journal-title":"Environ. Sci. Technol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1080\/14767058.2017.1402000","article-title":"Placental transfer of bromocriptine in an ex vivo human placental perfusion model","volume":"32","author":"Zheng","year":"2019","journal-title":"J. Matern. Fetal Neonatal Med."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1694886\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:21:07Z","timestamp":1761546067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1694886\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":150,"alternative-id":["10.3389\/fphar.2025.1694886"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1694886","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"article-number":"1694886"}}